VEGFA rs3025020 Polymorphism Contributes to CALR-Mutation Susceptibility and Is Associated with Low Risk of Deep Vein Thrombosis in Primary Myelofibrosis

Background Single nucleotide polymorphisms (SNPs) in vascular endothelial growth factor A (VEGFA) are associated with susceptibility to several diseases including cancer. Correlations between VEGFA rs3025020 genotypes with clinical and laboratory features of primary myelofibrosis (PMF) are unstudied...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Laura Villani, Vittorio Rosti, Margherita Massa, Rita Campanelli, Paolo Catarsi, Adriana Carolei, Carlotta Abbà, Annalisa de Silvstri, Robert Peter Gale, Giovanni Barosi
Formato: article
Lenguaje:EN
Publicado: Georg Thieme Verlag KG 2021
Materias:
Acceso en línea:https://doaj.org/article/e906254e58584b989aaa9b12fede141e
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:e906254e58584b989aaa9b12fede141e
record_format dspace
spelling oai:doaj.org-article:e906254e58584b989aaa9b12fede141e2021-11-09T23:57:38ZVEGFA rs3025020 Polymorphism Contributes to CALR-Mutation Susceptibility and Is Associated with Low Risk of Deep Vein Thrombosis in Primary Myelofibrosis2512-946510.1055/s-0041-1739293https://doaj.org/article/e906254e58584b989aaa9b12fede141e2021-10-01T00:00:00Zhttp://www.thieme-connect.de/DOI/DOI?10.1055/s-0041-1739293https://doaj.org/toc/2512-9465Background Single nucleotide polymorphisms (SNPs) in vascular endothelial growth factor A (VEGFA) are associated with susceptibility to several diseases including cancer. Correlations between VEGFA rs3025020 genotypes with clinical and laboratory features of primary myelofibrosis (PMF) are unstudied. Methods DNA was analyzed by real-time polymerase chain reaction for VEGFA rs3025020 genotypes in a cohort of 844 subjects with PMF and in two cohorts of normal subjects (N = 247 and N = 107). Results Frequency of rs3025020 minor allele (T) was not significantly different in subjects with PMF compared with normals; however, the T-allele was more frequent in PMF subjects with a calreticulin (CALR)-mutated genotype compared with normals (35 vs. 27%; OR = 1.47 [95% CI, 1.09, 1.98] p = 0.011), especially in subjects with a CALR-type 2/type 2-like mutation (43 vs. 27%; OR = 2.01 [1.25, 3.24] p = 0.004). CALR mutants with the rs3025020 TT genotype had higher CXCR4 expression on CD34-positive blood cells, and those who carried CT/TT genotypes had lower platelet concentrations compared with other genotypes at diagnosis. Overall, subjects with the rs3025020 CT/TT genotype had a lower cumulative incidence of deep vein thrombosis in typical sites (1.6 vs. 4.2%; OR = 0.37 [0.15, 0.90] p = 0.029) and longer interval from diagnosis to first thrombosis (HR = 0.37 [0.14, 0.95] p = 0.039). Conclusion Persons with PMF and the VEGFA rs3025020 minor T-allele are more likely to have a CALR mutation compared with other somatic driver mutations and lower cumulative incidence and hazard for deep vein thrombosis in typical sites.Laura VillaniVittorio RostiMargherita MassaRita CampanelliPaolo CatarsiAdriana CaroleiCarlotta AbbàAnnalisa de SilvstriRobert Peter GaleGiovanni BarosiGeorg Thieme Verlag KGarticleprimary myelofibrosis vegfa polymorphism rs3025020 deep vein thrombosis calr mutationDiseases of the circulatory (Cardiovascular) systemRC666-701ENTH Open, Vol 05, Iss 04, Pp e513-e520 (2021)
institution DOAJ
collection DOAJ
language EN
topic primary myelofibrosis
vegfa polymorphism
rs3025020
deep vein thrombosis
calr mutation
Diseases of the circulatory (Cardiovascular) system
RC666-701
spellingShingle primary myelofibrosis
vegfa polymorphism
rs3025020
deep vein thrombosis
calr mutation
Diseases of the circulatory (Cardiovascular) system
RC666-701
Laura Villani
Vittorio Rosti
Margherita Massa
Rita Campanelli
Paolo Catarsi
Adriana Carolei
Carlotta Abbà
Annalisa de Silvstri
Robert Peter Gale
Giovanni Barosi
VEGFA rs3025020 Polymorphism Contributes to CALR-Mutation Susceptibility and Is Associated with Low Risk of Deep Vein Thrombosis in Primary Myelofibrosis
description Background Single nucleotide polymorphisms (SNPs) in vascular endothelial growth factor A (VEGFA) are associated with susceptibility to several diseases including cancer. Correlations between VEGFA rs3025020 genotypes with clinical and laboratory features of primary myelofibrosis (PMF) are unstudied. Methods DNA was analyzed by real-time polymerase chain reaction for VEGFA rs3025020 genotypes in a cohort of 844 subjects with PMF and in two cohorts of normal subjects (N = 247 and N = 107). Results Frequency of rs3025020 minor allele (T) was not significantly different in subjects with PMF compared with normals; however, the T-allele was more frequent in PMF subjects with a calreticulin (CALR)-mutated genotype compared with normals (35 vs. 27%; OR = 1.47 [95% CI, 1.09, 1.98] p = 0.011), especially in subjects with a CALR-type 2/type 2-like mutation (43 vs. 27%; OR = 2.01 [1.25, 3.24] p = 0.004). CALR mutants with the rs3025020 TT genotype had higher CXCR4 expression on CD34-positive blood cells, and those who carried CT/TT genotypes had lower platelet concentrations compared with other genotypes at diagnosis. Overall, subjects with the rs3025020 CT/TT genotype had a lower cumulative incidence of deep vein thrombosis in typical sites (1.6 vs. 4.2%; OR = 0.37 [0.15, 0.90] p = 0.029) and longer interval from diagnosis to first thrombosis (HR = 0.37 [0.14, 0.95] p = 0.039). Conclusion Persons with PMF and the VEGFA rs3025020 minor T-allele are more likely to have a CALR mutation compared with other somatic driver mutations and lower cumulative incidence and hazard for deep vein thrombosis in typical sites.
format article
author Laura Villani
Vittorio Rosti
Margherita Massa
Rita Campanelli
Paolo Catarsi
Adriana Carolei
Carlotta Abbà
Annalisa de Silvstri
Robert Peter Gale
Giovanni Barosi
author_facet Laura Villani
Vittorio Rosti
Margherita Massa
Rita Campanelli
Paolo Catarsi
Adriana Carolei
Carlotta Abbà
Annalisa de Silvstri
Robert Peter Gale
Giovanni Barosi
author_sort Laura Villani
title VEGFA rs3025020 Polymorphism Contributes to CALR-Mutation Susceptibility and Is Associated with Low Risk of Deep Vein Thrombosis in Primary Myelofibrosis
title_short VEGFA rs3025020 Polymorphism Contributes to CALR-Mutation Susceptibility and Is Associated with Low Risk of Deep Vein Thrombosis in Primary Myelofibrosis
title_full VEGFA rs3025020 Polymorphism Contributes to CALR-Mutation Susceptibility and Is Associated with Low Risk of Deep Vein Thrombosis in Primary Myelofibrosis
title_fullStr VEGFA rs3025020 Polymorphism Contributes to CALR-Mutation Susceptibility and Is Associated with Low Risk of Deep Vein Thrombosis in Primary Myelofibrosis
title_full_unstemmed VEGFA rs3025020 Polymorphism Contributes to CALR-Mutation Susceptibility and Is Associated with Low Risk of Deep Vein Thrombosis in Primary Myelofibrosis
title_sort vegfa rs3025020 polymorphism contributes to calr-mutation susceptibility and is associated with low risk of deep vein thrombosis in primary myelofibrosis
publisher Georg Thieme Verlag KG
publishDate 2021
url https://doaj.org/article/e906254e58584b989aaa9b12fede141e
work_keys_str_mv AT lauravillani vegfars3025020polymorphismcontributestocalrmutationsusceptibilityandisassociatedwithlowriskofdeepveinthrombosisinprimarymyelofibrosis
AT vittoriorosti vegfars3025020polymorphismcontributestocalrmutationsusceptibilityandisassociatedwithlowriskofdeepveinthrombosisinprimarymyelofibrosis
AT margheritamassa vegfars3025020polymorphismcontributestocalrmutationsusceptibilityandisassociatedwithlowriskofdeepveinthrombosisinprimarymyelofibrosis
AT ritacampanelli vegfars3025020polymorphismcontributestocalrmutationsusceptibilityandisassociatedwithlowriskofdeepveinthrombosisinprimarymyelofibrosis
AT paolocatarsi vegfars3025020polymorphismcontributestocalrmutationsusceptibilityandisassociatedwithlowriskofdeepveinthrombosisinprimarymyelofibrosis
AT adrianacarolei vegfars3025020polymorphismcontributestocalrmutationsusceptibilityandisassociatedwithlowriskofdeepveinthrombosisinprimarymyelofibrosis
AT carlottaabba vegfars3025020polymorphismcontributestocalrmutationsusceptibilityandisassociatedwithlowriskofdeepveinthrombosisinprimarymyelofibrosis
AT annalisadesilvstri vegfars3025020polymorphismcontributestocalrmutationsusceptibilityandisassociatedwithlowriskofdeepveinthrombosisinprimarymyelofibrosis
AT robertpetergale vegfars3025020polymorphismcontributestocalrmutationsusceptibilityandisassociatedwithlowriskofdeepveinthrombosisinprimarymyelofibrosis
AT giovannibarosi vegfars3025020polymorphismcontributestocalrmutationsusceptibilityandisassociatedwithlowriskofdeepveinthrombosisinprimarymyelofibrosis
_version_ 1718440798821810176